Kris Mathey, MS, NP-C, AOCNP®
Historically, the basis of cancer treatment resided in the use of surgery, chemotherapy, and radiation therapy. However, over the past couple of decades, cancer treatment has advanced by leaps and bounds, with the emergence first of targeted therapy and then, most recently, immunotherapy, which has come to the forefront of this revolution. Immunotherapy targets the patient’s own immune system to attack tumors and has become thought of as the fifth pillar of cancer treatment.
One rapidly emerging immunotherapy approach is the use of CAR T-cell therapy. “CAR T: Where We Are and Where We Are Going” is a great addition to the Advanced Practice track at Congress this year.
During this session, a physician and an advanced practice nurse will jointly discuss the rationale for CAR T-cell therapy, as well as strategies for the novel management of patients.
Don’t miss this exciting session on CAR T-cell therapy on Saturday, April 13, from 2:45 to 4 pm, in room 257 of the Anaheim Convention Center.